查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869672

人工智慧在患者预约管理软体市场规模、份额和趋势分析报告（按预约管理类型、部署模式、最终用途、地区和细分市场预测，2025-2033 年）

AI In Patient Scheduling Software Market Size, Share & Trends Analysis Report By Scheduling Type, By Deployment Mode, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

人工智慧在患者预约管理软体市场摘要

2024 年全球人工智慧在患者预约管理软体市场规模估计为 6,304 万美元，预计到 2033 年将达到 5.5509 亿美元。

预计从 2025 年到 2033 年，该市场将以 27.64% 的复合年增长率成长。减少行政低效率和提高医疗资源利用率的需求不断增长，医疗保健系统正在快速进行数位转型，以及远距远端医疗和基于价值的医疗模式的兴起，都是推动市场成长的因素。

此外，不断增长的患者群体、日益加重的慢性病负担以及对以患者为中心的医疗服务和便利性的日益重视，也推动了市场成长。推动人工智慧在患者预约管理软体中应用的关键因素在于，需要减少行政效率低下并更有效地利用医疗资源。传统的人工预约系统经常导致瓶颈、重复预约和患者长时间等待。人工智慧平台透过分析即时医生可用性、患者偏好和临床紧急程度来优化预约分配。这提高了营运效率，降低了爽约率，并提升了患者容量。此外，随着患者数量的不断增加，医疗服务提供者正在加速采用人工智慧排班系统来简化工作流程。例如，2025年2月，Innovaccer发布了“Agents of Care”，这是一个面向医疗服务提供者的人工智慧代理套件，可自动执行低附加价值的医疗行政任务，例如预约管理、通讯协定输入、转诊管理和病患咨询回覆。

此外，人们越来越重视透过数位互动和便利性来改善患者体验，这推动了人工智慧在患者预约管理软体中的应用。患者越来越期望获得无缝的自助服务选项，例如线上预约和即时改期，就像他们在其他消费品行业一样。人工智慧预约系统透过为患者入口网站和行动应用程式提供基于既往就诊记录、治疗计划和医生出诊情况的智慧提案来实现这一点。这些解决方案有助于提高患者满意度，促进后续护理的连续性，并增强患者对医生的信任。例如，Epic Systems 于 2025 年 5 月推出了一款互动式人工智慧工具，让患者透过简讯预约，无需登入入口网站或等待电话。人工智慧助理会发起预约对话，提案可用时段，确认预约，并提供 MyChart 连结以便查看更多详情并进行线上註册。

远端医疗和基于价值的医疗模式的兴起凸显了人工智慧在患者预约软体中日益广泛的应用。虚拟医疗平台依赖智慧预约系统来管理大量的线上预约，同时协调不同地理和时区的医疗服务提供者。同样，在基于价值的医疗模式中，精准的预约管理对于最大限度地减少就诊延误、确保及时干预和优化患者疗效至关重要。例如，2025年7月，拉什大学医疗系统推出了“Rush Connect+”，这是一项面向全国远端医疗会员服务，提供全天候虚拟咨询。服务包括：人工客服协助预约和解答疑问、人工智慧聊天机器人、症状自查工具，以及八个领域的当日专科诊疗服务。

目录

第一章调查方法和范围

第二章执行摘要

3. 人工智慧在患者预约管理软体市场的应用：市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 人工智慧在患者预约管理软体中的市场：分析工具
    • 产业分析—波特五力分析
    • PESTEL 分析
  • 案例研究见解
  • 技术概述

第四章 人工智慧在病患预约管理软体中的市场：按预约管理类型分類的估算和趋势分析

  • 细分仪表板
  • 按预订管理类型进行的波动分析
  • 2021-2033年全球人工智慧市场规模及趋势分析（按预约管理类型分類的患者预约管理软体）
  • 门诊治疗计划
  • 住院安排
  • 特殊护理计划
  • 急诊和紧急护理安排
  • 其他的

5. 人工智慧在病患预约管理软体中的市场：按部署模式分類的估算和趋势分析

  • 细分仪表板
  • 依部署模式进行波动分析
  • 2021-2033年全球人工智慧在病患预约管理软体市场规模及趋势分析（按部署模式划分）
  • 云端基础的
  • 本地部署

6. 人工智慧在患者预约管理软体市场的应用：按最终用户分類的估算和趋势分析

  • 细分仪表板
  • 依最终用途进行变异分析
  • 全球人工智慧在病患预约管理软体市场规模及趋势分析（按最终用途划分，2021-2033年）
  • 医院
  • 诊所
  • 诊断和影像中心
  • 门诊手术中心（ASC）
  • 其他的

7. 人工智慧在病患预约管理软体中的市场：区域估算与趋势分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场概览
  • 市场规模及预测趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司/竞争对手分类
  • 策略规划
  • 企业市场分析，2024年
  • 公司简介/上市公司
    • Veradigm LLC
    • Hyro
    • Epic Systems Corporation
    • Assort Health
    • Notable
    • Voiceoc
    • Zocdoc
    • Relatient
    • UnityAI, Inc.
Product Code: GVR-4-68040-768-5

AI In Patient Scheduling Software Market Summary

The global AI in patient scheduling software market size was estimated at USD 63.04 million in 2024 and is projected to reach USD 555.09 million by 2033, growing at a CAGR of 27.64% from 2025 to 2033. Growing need to reduce administrative inefficiencies and improve healthcare resource utilization, rapid digital transformation across healthcare systems, and the rise of telehealth and value-based care models are some factors contributing to market growth.

In addition, rising patient volumes, chronic disease burden, and increasing emphasis on patient-centric care and convenience contribute to market growth. The adoption of AI in patient scheduling software is primarily driven by the need to reduce administrative inefficiencies and improve healthcare resource utilization. Traditional manual scheduling systems often lead to bottlenecks, double bookings, and extended patient wait times. AI-powered platforms optimize appointment allocation by analyzing real-time provider availability, patient preferences, and clinical urgency. This results in higher operational efficiency, reduced no-show rates, and improved patient throughput. In addition, due to the rising patient volumes, healthcare providers are increasingly adopting AI scheduling systems to streamline workflows. For instance, in February 2025, Innovaccer introduced "Agents of Care," a suite of AI agents for healthcare providers that automate low-value healthcare administrative tasks like appointment scheduling, protocol intake, referral management, and patient inquiries.

Moreover, increasing emphasis on enhancing patient experience through digital engagement and convenience propels the growth of the AI in patient scheduling software industry. Patients increasingly expect seamless self-service options such as online booking and real-time rescheduling, similar to experiences in other consumer industries. AI scheduling systems facilitate this by offering patient-friendly portals and mobile applications with intelligent recommendations based on prior visits, treatment timelines, and provider availability. These solutions improve patient satisfaction, encourage adherence to follow-up care, and foster trust in healthcare providers. For instance, in May 2025, Epic Systems introduced a conversational AI tool that enables patients to schedule appointments via SMS without logging into a portal or waiting on hold. The AI assistant initiates scheduling conversations, offers appointment slots, confirms bookings, and provides MyChart links for details or virtual check-in.

The rise of telehealth and value-based care models highlights the increasing use of AI in patient scheduling software. Virtual care platforms depend on intelligent scheduling systems to manage a high volume of digital appointments while coordinating providers across different geographies and time zones. Similarly, value-based care models necessitate precise scheduling to minimize delays in care, ensure timely interventions, and optimize patient outcomes. For instance, in July 2025, Rush University System for Health launched Rush Connect+, a national direct-to-consumer telehealth membership offering 24/7 virtual urgent care. The service includes access to a human assistant for scheduling appointments and answering questions, AI-powered chatbots, symptom checkers, and same-day specialty care in eight areas.

Global AI In Patient Scheduling Software Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global AI in patient scheduling software market report based on scheduling type, deployment mode, end use, and region:

  • Scheduling Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Outpatient Scheduling
  • Inpatient Scheduling
  • Specialty Care Scheduling
  • Emergency & Urgent Care Scheduling
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloud-based
  • On-Premises
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Clinics
  • Diagnostic & Imaging Centers
  • Ambulatory Surgical Centers (ASCs)
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Scheduling Type Segment
    • 1.2.2. Deployment Mode Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Mode
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. AI in Patient Scheduling Software Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. AI in Patient Scheduling Software Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Environmental Landscape
      • 3.3.2.5. Legal Landscape
      • 3.3.2.6. Social Landscape
  • 3.4. Case Study Insights
  • 3.5. Technology Overview

Chapter 4. AI in Patient Scheduling Software Market: Scheduling Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global AI in Patient Scheduling Software Market Scheduling Type Movement Analysis
  • 4.3. Global AI in Patient Scheduling Software Market Size & Trend Analysis, by Scheduling Type, 2021 to 2033 (USD Million)
  • 4.4. Outpatient Scheduling
    • 4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5. Inpatient Scheduling
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Specialty Care Scheduling
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Emergency & Urgent Care Scheduling
    • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. AI in Patient Scheduling Software Market: Deployment Mode Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global AI in Patient Scheduling Software Market Deployment Mode Movement Analysis
  • 5.3. Global AI in Patient Scheduling Software Market Size & Trend Analysis, by Deployment Mode, 2021 to 2033 (USD Million)
  • 5.4. Cloud-based
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. On-Premises
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. AI in Patient Scheduling Software Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global AI in Patient Scheduling Software Market End Use Movement Analysis
  • 6.3. Global AI in Patient Scheduling Software Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5. Clinics
    • 6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Diagnostic & Imaging Centers
    • 6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Ambulatory Surgical Centers (ASCs)
    • 6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. AI in Patient Scheduling Software Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Veradigm LLC
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Hyro
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Epic Systems Corporation
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Assort Health
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Notable
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Voiceoc
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Zocdoc
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Relatient
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. UnityAI, Inc.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global AI in patient scheduling software market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 4 Global AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 5 Global AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 6 North America AI in patient scheduling software market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 8 North America AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 9 North America AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 10 U.S. AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 11 U.S. AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 12 U.S. AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Canada AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 14 Canada AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 15 Canada AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Mexico AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 17 Mexico AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 18 Mexico AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe AI in patient scheduling software market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 21 Europe AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 22 Europe AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 24 UK AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 25 UK AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Germany AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 27 Germany AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 28 Germany AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 29 France AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 30 France AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 31 France AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Italy AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 33 Italy AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 34 Italy AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 36 Spain AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 37 Spain AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 38 Denmark AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 39 Denmark AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 40 Denmark AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 41 Sweden AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 42 Sweden AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 43 Sweden AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Norway AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 45 Norway AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 46 Norway AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific AI in patient scheduling software market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 51 China AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 52 China AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 53 China AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 54 Japan AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 55 Japan AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 56 Japan AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 57 India AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 58 India AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 59 India AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 60 South Korea AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 61 South Korea AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 62 South Korea AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Australia AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 64 Australia AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 65 Australia AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 66 Thailand AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 67 Thailand AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 68 Thailand AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Latin America AI in patient scheduling software market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 71 Latin America AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 72 Latin America AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 73 Brazil AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 74 Brazil AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 75 Brazil AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 76 Argentina AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 77 Argentina AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 78 Argentina AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 79 MEA AI in patient scheduling software market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 81 MEA AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 82 MEA AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 83 South Africa AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 84 South Africa AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 85 South Africa AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 89 UAE AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 90 UAE AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 91 UAE AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait AI in patient scheduling software market, by scheduling type, 2021 - 2033 (USD Million)
  • Table 93 Kuwait AI in patient scheduling software market, by deployment mode, 2021 - 2033 (USD Million)
  • Table 94 Kuwait AI in patient scheduling software market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 AI in patient scheduling software market: Market outlook
  • Fig. 5 AI in patient scheduling software market: Segment outlook
  • Fig. 6 AI in patient scheduling software market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 AI in patient scheduling software market driver impact
  • Fig. 9 AI in patient scheduling software market restraint impact
  • Fig. 10 AI in patient scheduling software market: Scheduling type outlook and key takeaways
  • Fig. 11 AI in patient scheduling software market: Scheduling type movement analysis
  • Fig. 12 Outpatient scheduling market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Inpatient scheduling market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Specialty care scheduling market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Emergency & urgent care scheduling market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 AI in patient scheduling software market: Deployment mode outlook and key takeaways
  • Fig. 18 AI in patient scheduling software market: Deployment mode movement analysis
  • Fig. 19 Cloud-based market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 20 On-premises market estimates and forecasts,2021 - 2033 (USD Million)
  • Fig. 21 AI in patient scheduling software market: End use outlook and key takeaways
  • Fig. 22 AI in patient scheduling software market: End use movement analysis
  • Fig. 23 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Clinics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Diagnostic & imaging centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Ambulatory surgical centers (ASCs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Global AI in patient scheduling software market: Regional outlook and key takeaways
  • Fig. 29 Global AI in patient scheduling software market: Regional movement analysis
  • Fig. 30 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. key country dynamics
  • Fig. 32 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Canada key country dynamics
  • Fig. 34 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Mexico key country dynamics
  • Fig. 36 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 UK key country dynamics
  • Fig. 39 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Germany key country dynamics
  • Fig. 41 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 France key country dynamics
  • Fig. 43 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Italy key country dynamics
  • Fig. 45 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Spain key country dynamics
  • Fig. 47 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Denmark key country dynamics
  • Fig. 49 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Sweden key country dynamics
  • Fig. 51 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Norway key country dynamics
  • Fig. 53 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Japan key country dynamics
  • Fig. 56 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 China key country dynamics
  • Fig. 58 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 India key country dynamics
  • Fig. 60 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Thailand key country dynamics
  • Fig. 62 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 South Korea key country dynamics
  • Fig. 64 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Australia key country dynamics
  • Fig. 66 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Brazil key country dynamics
  • Fig. 69 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Argentina key country dynamics
  • Fig. 71 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 South Africa key country dynamics
  • Fig. 74 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Saudi Arabia key country dynamics
  • Fig. 76 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 UAE key country dynamics
  • Fig. 78 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Kuwait key country dynamics
  • Fig. 80 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)